Yoshiko Suzuki

Receptor Binding, Behavioral, and Electrophysiological Profiles of Nonpeptide Corticotropin-Releasing Factor Subtype 1 Receptor Antagonists CRA1000 and CRA1001

Shigeru Okuyama, Shigeyuki Chaki, Naoya Kawashima et al. · Journal of Pharmacology and Experimental Therapeutics · 1999 · 153 citations · Full text

Medicine, Neuroscience, Pharmacology +15

A Conceptual Definition of Vocational Rehabilitation Based on the ICF: Building a Shared Global Model

Reuben Escorpizo, Michiel F. Reneman, Jan Ekholm et al. · Journal of Occupational Rehabilitation · 2011 · 152 citations

Education, Rehabilitation Medicine, Vocational Education +15

Anxiolytic-Like and Antidepressant-Like Activities of MCL0129 (1-[(S)-2-(4-Fluorophenyl)-2-(4-isopropylpiperadin-1-yl)ethyl]-4-[4-(2-methoxynaphthalen-1-yl)butyl]piperazine), a Novel and Potent Nonpeptide Antagonist of the Melanocortin-4 Receptor

Shigeyuki Chaki, Shiho Hirota, Takeo Funakoshi et al. · Journal of Pharmacology and Experimental Therapeutics · 2003 · 118 citations · Full text

Medicine, Neuroscience, Pharmacology +14

Synthesis, SARs, and Pharmacological Characterization of 2-Amino-3 or 6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Derivatives as Potent, Selective, and Orally Active Group II Metabotropic Glutamate Receptor Agonists

Atsuro Nakazato, Toshihito Kumagai, Kazunari Sakagami et al. · Journal of Medicinal Chemistry · 2000 · 114 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

Cocaine- and amphetamine-regulated transcript peptide produces anxiety-like behavior in rodents

Shigeyuki Chaki, Naoya Kawashima, Yoshiko Suzuki et al. · European Journal of Pharmacology · 2003 · 98 citations

Life Sciences, Neurobiology, Neuroscience +13